Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women

Sponsored by Pierre Fabre Dermo Cosmetique

About this trial

Last updated 6 years ago

Study ID

STRESSCARBONYL2

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Accepting

18 to 40 Years

Female

Trial Timing

Ended 6 years ago

What is this trial about?

In this study, the investigator will try to highlight the presence of carbonyl compounds in the hair follicles of postpartum women by comparing these compounds before and after delivery.

What are the participation requirements?

Inclusion Criteria

Criteria related to the Population: * Pregnant woman (≥ 33 weeks of amenorrhea) * Woman aged between 18 and 40 years (included) * Phototype I to IV included according to Fitzpatrick's classification * Affiliation to a French social security scheme or benefiting from such a scheme * Signed informed consent form

Exclusion Criteria

Criteria related to the Population: * High risk or pathological pregnancy, according to the opinion of the investigator * Deprivation of liberty by administrative or judicial decision or subject under guardianship * Impossibility, according to the investigator, to comply with the requirements of the protocol * Linguistic or psychic incapacity to sign informed consent * Concomitant participation in a clinical study that may interfere with the results of the study, according to the opinion of the investigator (excluding observational studies) Criteria related to Pathology : * Alopecia causing hair loss on the upper part of the scalp * Dermatological pathology or evolving cutaneous lesion in the scalp * Known history of hepatitis B and C, HIV * Past or present neoplastic condition * Acute evolving pathology * Gestational diabetes treated with insulin Criteria related to Treatments: * Treatment of general thyroid disorders initiated or modified for less than 3 months prior to inclusion (or change of specialty for less than 3 months) * Systemic treatment affecting hair growth taken for at least 4 weeks during the 3 months prior to inclusion * Systemic treatment: nonsteroidal anti-inflammatory drug, corticosteroid, antibiotic, antihistamine taken for 5 consecutive days within 2 weeks prior to inclusion or that may interfere with the results of the study according to the investigator, * Dermal use, for at least 4 weeks, of Minoxidil, Aminexil within 3 months prior to inclusion * Dermal use in the 4 weeks prior to inclusion, of any product that may be active on the hair follicle and scalp or may affect the dosage of carbonyl compounds (including hair dyes) * Last shampoo less than 2 days before the inclusion and application of styling / care products (gel, lacquer, wax, conditioner ...) or water between the last shampoo and the inclusion